Cargando…
Targeting cysteine-rich angiogenic inducer-61 by antibody immunotherapy suppresses growth and migration of non-small cell lung cancer
Autores principales: | Li, Xinpeng, Yuan, Naxin, Lin, Lingdan, Yin, Lixia, Qu, Yiqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185803/ https://www.ncbi.nlm.nih.gov/pubmed/35720625 http://dx.doi.org/10.3892/etm.2022.11365 |
Ejemplares similares
-
Targeting cysteine-rich angiogenic inducer-61 by antibody immunotherapy suppresses growth and migration of non-small cell lung cancer
por: Li, Xinpeng, et al.
Publicado: (2018) -
Role of cysteine-rich angiogenic inducer 61 in fibroblast-like synovial cell proliferation and invasion in rheumatoid arthritis
por: JIE, LI-GANG, et al.
Publicado: (2015) -
Role of cysteine-rich angiogenic inducer 61 in fibroblast-like synovial cell proliferation and invasion in rheumatoid arthritis
por: Jie, Li-Gang, et al.
Publicado: (2022) -
Cysteine-Rich Angiogenic Inducer 61 Serves as a Potential Serum Biomarker for the Remission of Adult-Onset Still's Disease
por: Su, Yutong, et al.
Publicado: (2019) -
Cysteine-Rich Angiogenic Inducer 61: Pro-Survival Function and Role as a Biomarker for Disseminating Breast Cancer Cells
por: Bartkowiak, Kai, et al.
Publicado: (2021)